Will Augmentin (amoxicillin-clavulanate) treat conjunctivitis that occurs with streptococcal (strep) infection simultaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis with Concurrent Strep Infection

Augmentin (amoxicillin-clavulanate) is effective for treating conjunctivitis that occurs simultaneously with streptococcal infection, as it provides coverage for both ocular and systemic manifestations of streptococcal disease. 1, 2

Bacterial Conjunctivitis Treatment Approach

  • For mild bacterial conjunctivitis (including streptococcal), a 5-7 day course of broad-spectrum topical antibiotics is usually effective, reducing symptom duration and improving clinical outcomes 1, 2
  • Topical antibiotic therapy shortens the duration of clinical disease and enhances eradication of causative organisms from the conjunctiva 3
  • Approximately one-third of streptococcal isolates may not be sensitive to gentamicin, making broad-spectrum coverage important 4

Treatment for Concurrent Streptococcal Infection with Conjunctivitis

  • When conjunctivitis occurs simultaneously with streptococcal infection (such as strep throat), systemic antibiotic therapy is necessary to address both conditions 1, 2
  • Augmentin (amoxicillin-clavulanate) at a dose of 875/125 mg twice daily for adults or 25 mg/kg/day of the amoxicillin component in 2 divided doses for children is appropriate for treating both conditions 1
  • This combination provides coverage against streptococcal species and potential co-infecting organisms that may produce beta-lactamase 1, 5

Specific Considerations for Streptococcal Conjunctivitis

  • Streptococcal conjunctivitis typically presents with mucopurulent discharge, conjunctival injection, and possible preauricular lymphadenopathy 1
  • Obtaining conjunctival cultures before initiating treatment is recommended for moderate to severe infections to guide appropriate antibiotic selection 1
  • Patients should be advised to return for follow-up if symptoms don't improve within 3-4 days of treatment 1

Special Populations and Situations

  • For pregnant women with bacterial conjunctivitis, amoxicillin 500 mg orally three times a day for 7 days is recommended 1
  • In children, Augmentin dosing should be adjusted based on weight (25 mg/kg/day of the amoxicillin component in 2 divided doses) 1
  • For patients with severe conjunctivitis or those who don't respond to initial therapy, conjunctival cultures should be obtained to guide antibiotic selection 1

Potential Pitfalls and Caveats

  • Bacterial resistance is a growing concern in the treatment of conjunctivitis; using appropriate broad-spectrum antibiotics like Augmentin helps address this issue 5
  • Poor adherence to prescribed regimens can affect treatment success; patients should be counseled on the importance of completing the full course of antibiotics 5
  • Topical corticosteroids should generally be avoided in infectious conjunctivitis unless specifically indicated for severe inflammation, as they may worsen certain infections 6
  • If symptoms persist despite appropriate antibiotic therapy, consider alternative diagnoses or resistant organisms 1, 5

Follow-up Recommendations

  • Patients should be advised to return for follow-up if symptoms don't improve within 3-4 days of treatment initiation 1
  • For moderate to severe cases, a follow-up visit should include interval history, visual acuity measurement, and slit-lamp biomicroscopy 1
  • Complete resolution of bacterial conjunctivitis, even with appropriate treatment, may take 7-10 days 3, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

Comparison of three topical antimicrobials for acute bacterial conjunctivitis.

The Pediatric infectious disease journal, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.